Ensemble Capital acquired 340k Masimo shares worth $61.2M. That's 5.66% of their entire equity portfolio (6th largest holding). The first Masimo trade was made in Q1 2019. Since then Ensemble Capital bought shares fifteen more times and sold shares on seven occasions. The stake costed the investor $60.9M, netting the investor a gain of 0.5% so far.
Medical device maker Masimo Corp on Tuesday said it has started litigation against Politan Capital in a California federal court, seeking to force the activi...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and au...
NEW YORK--(BUSINESS WIRE)--Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “...
Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary." The unusually sharp r...